Anti-Human IL-12/IL-23 p40 Reference Antibody (Ustekinumab, RUO)

Description: Ustekinumab (BS10587) is a research-grade recombinant antibody targeting IL-12 subunit p40. Produced in mammalian cells with native-like glycosylation.
Highlights:
• Research Grade — For PK/PD studies, assay development, and ADA research.
• Native Glycosylation — Mammalian expression ensures native-like patterns.
Host species: Human
Isotype: IgG1-kappa
Species reactivity: Human
Immunogen:
Form: Liquid
Storage instructions:
Storage buffer: 0.01M PBS, pH7.4.
Concentration: 1.18mg/ml
Purity: >95% as determined by SDS-PAGE.
Clonality: Monoclonal
Applications: Research Grade Biosimilar
Target: IL-12subunitp40,IL12B,Interleukin-12subunitbeta,IL-12B,CLMFp40,NKSF2,NKcellstimulatoryfactorchain2,Cytotoxiclymphocytematurationfactor40kDasubunit
Purification: Protein A/G purified from cell culture supernatant.
Endotoxin level: <1EU/mg, determined by LAL gel clotting assay
Expression system: Mammalian Cells
Stability and Storage: Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks). Store at -20°C 12 months. Store at -80°C long term.
Alternative Names: CNTO1275,TT-20,BFI-751,AVT04,CAS:815610-63-0
Background: Ebdarokimab (AK101) is a humanized IgG1-κ antibody, usually expressed in CHO (Chinese Hamster Ovary) cells.
Note: For research use only. Not suitable for clinical or therapeutic use.